Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Kinase inhibitors: not just for kinases anymore.

McGovern SL, Shoichet BK.

J Med Chem. 2003 Apr 10;46(8):1478-83.

PMID:
12672248
2.

Screening in a spirit haunted world.

Shoichet BK.

Drug Discov Today. 2006 Jul;11(13-14):607-15. Review.

3.

Discovery of highly selective inhibitors of p38alpha.

Popa-Burke I, Birkos S, Blackwell L, Cheatham L, Clark J, Dickson JK Jr, Galasinski S, Janzen WP, Mendoza J, Miller JL, Mohney RP, Steed PM, Hodge CN.

Curr Top Med Chem. 2005;5(10):941-51. Review.

PMID:
16178739
4.

Turning promiscuous kinase inhibitors into safer drugs.

Zhang X, Crespo A, Fernández A.

Trends Biotechnol. 2008 Jun;26(6):295-301. doi: 10.1016/j.tibtech.2008.02.008. Epub 2008 Apr 9. Review.

PMID:
18403035
5.

Kinomics-structural biology and chemogenomics of kinase inhibitors and targets.

Vieth M, Higgs RE, Robertson DH, Shapiro M, Gragg EA, Hemmerle H.

Biochim Biophys Acta. 2004 Mar 11;1697(1-2):243-57. Review.

PMID:
15023365
6.

[Reactions of derivatives of beta-lactam antibiotics with non-antibacterial biological activity].

Gunda T.

Acta Pharm Hung. 2002;72(4):223-30. Review. Hungarian.

PMID:
12812042
7.

Chemical genetic approaches to kinase drug discovery.

Gallion SL, Qian D.

Curr Opin Drug Discov Devel. 2005 Sep;8(5):638-45. Review.

PMID:
16159026
8.
9.

Mitogen activated protein (MAP) kinases: development of ATP and non-ATP dependent inhibitors.

Hancock CN, Macias AT, Mackerell AD Jr, Shapiro P.

Med Chem. 2006 Mar;2(2):213-22. Review.

PMID:
16787369
10.

Kinase selectivity profiling by inhibitor affinity chromatography.

Valsasina B, Kalisz HM, Isacchi A.

Expert Rev Proteomics. 2004 Oct;1(3):303-15. Review.

PMID:
15966827
11.

Cyclin-dependent kinase inhibitors.

Fischer PM, Endicott J, Meijer L.

Prog Cell Cycle Res. 2003;5:235-48. Review.

PMID:
14593718
12.
Items per page

Supplemental Content

Write to the Help Desk